
Cooperberg says a growing body of evidence dictates that surgery in prostate cancer may be a more effective local therapy than radiation alone.

Your AI-Trained Oncology Knowledge Connection!


Cooperberg says a growing body of evidence dictates that surgery in prostate cancer may be a more effective local therapy than radiation alone.

Cooperberg says the likelihood of a patient for staying on active surveillance for 10 or 15 years is around 50%, though men who stay on active surveillance for between 6 months and 5 years generally see progression in their disease.

Matthew Cooperberg, MD, genitourinary cancer specialist, University of California San Francisco, discusses the appropriateness of a more aggressive approach to men with high-risk prostate cancer. Cooperberg says currently, men will normally respond to surgery followed by adjuvant radiotherapy, as well as systemic therapy.

Matthew Cooperberg, MD, genitourinary cancer specialist, University of California San Francisco, discusses the impact of immunotherapy on the treatment of prostate cancer. Cooperberg believes immunotherapy treatment should be used earlier in the course of the disease.

Published: August 6th 2015 | Updated:

Published: February 3rd 2016 | Updated:

Published: February 13th 2016 | Updated:

Published: March 19th 2016 | Updated: